COMMUNIQUÉS West-GlobeNewswire

IRADIMED CORPORATION to Hold 2018 First Quarter Financial Results Conference Call on April 30th

16/04/2018 - 13:00

WINTER SPRINGS, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD ) announced today that the Company will release its 2018 first quarter financial results before the market opens on Monday, [...]

Active Biotech's rights issue over subscribed

16/04/2018 - 12:40

2018-04-16 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD [...]

Share buy-back week 15/2018

16/04/2018 - 12:07

Announcement 16 April 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

PotNetwork Holdings, Inc. Purchases State of the Art Cryptocurrency Mining Facility

16/04/2018 - 12:00

With 115 Dedicated Cryptocurrency Mining Rigs, The Company Will Diversify By Establishing Itself In The Bitcoin Mining Industry FT LAUDERDALE, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork [...]

Gala Pharmaceutical to Launch Its First State-Of-The-Art Cannabis Testing Laboratories

16/04/2018 - 12:00

IRVINE, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (OTCBB: GLPH ), an emerging cannabis cloning and breeding company, today announced that it expects to build its first state-of-the-art testing [...]

G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer

16/04/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., April 16, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that it has initiated a Phase 1b/2 clinical trial assessing [...]

Transactions under Novozymes’ stock buyback program

16/04/2018 - 11:33

Please read the full announcement in the attached PDF 2018_14_Stock_Buybackprogram_EN Attachment 2018_14_Stock_Buybackprogram_EN

Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy

16/04/2018 - 08:01

Taiho Pharma ceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy Lugano, Switzerland, and Tokyo, Japan, [...]

Shire plc : Rule 2.9 Announcement

16/04/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 16 April 2018 [...]

Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema

16/04/2018 - 08:01

Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema Herantis Pharma Plc Company release 16 Apr 2018 at 9:00 am Herantis Pharma Plc ("Herantis") announced today positive results [...]

Lysogene Reports First Quarter Financial Results and Provides Business Update

16/04/2018 - 07:45

Extended CNS pipeline with a collaboration agreement for the development of an AAV-based gene therapy for Fragile X syndrome, the most common single gene cause of autism, a condition of high unmet medical need. [...]

Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes

16/04/2018 - 07:16

Heart failure (HF) patients with reduced ejection fraction treated with Entresto experienced significantly less reduction in kidney function compared to patients treated with standard of care ACE inhibitor enalapril[1] [...]

Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership

16/04/2018 - 02:15

MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]

NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG) Presented During AACR Plenary

15/04/2018 - 21:05

Early data indicate indoximod has clinical activity when used in combination therapies beyond PD-1 inhibition AMES, Iowa, April 15, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ), today reported [...]

Thousands of People with Epilepsy and their Loved Ones Participate in the 12th Annual National Walk for Epilepsy on the National Mall

14/04/2018 - 16:23

Contributions Fund Research, Programs and Services for 3.4 Million People in the U.S. Living with Seizures WASHINGTON, April 14, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation is hosting its 12 th Annual National Walk [...]

Albireo Reports Data on Pharmacodynamic Marker for A4250 in Children with Cholestatic Liver Disease at The International Liver Congress™ 2018

14/04/2018 - 14:00

— Correlation observed between reduction in serum bile acids and autotaxin with A4250 — — Autotaxin has potential to be important biomarker of cholestatic pruritus — BOSTON, April 14, 2018 (GLOBE NEWSWIRE) -- Albireo [...]

Bradmer Pharmaceuticals, Galaxy Digital and First Coin Announce Update

13/04/2018 - 23:20

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. TORONTO, April 13, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (“ Bradmer ”) (TSX VENTURE:BMR.H), Galaxy Digital LP (“ [...]

Paratek Appoints Rolf K. Hoffman to Company’s Board of Directors

13/04/2018 - 22:40

-- Led U.S. and International Commercial Operations at Amgen Inc.-- BOSTON, April 13, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and [...]

Avivagen Announces the Issuance of Stock Options

13/04/2018 - 22:15

OTTAWA, April 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]